TY - JOUR
T1 - The impact of health insurance coverage on racial/ethnic disparities in US childhood and adolescent cancer stage at diagnosis
AU - Wang, Xiaoyan
AU - Brown, Derek S.
AU - Cao, Yin
AU - Ekenga, Christine C.
AU - Guo, Shenyang
AU - Johnson, Kimberly J.
N1 - Publisher Copyright:
© 2022 American Cancer Society.
PY - 2022/9/1
Y1 - 2022/9/1
N2 - Background: Racial/ethnic minority children and adolescents are more likely to have an advanced cancer diagnosis compared with non-Hispanic Whites, which may relate to the lack of consistent health care access. This study aims to describe racial/ethnic disparities in cancer diagnosis stage among children and adolescents and assess whether health insurance mediates these disparities. Methods: Data on individuals ≤19 years of age diagnosed with primary cancers from 2007 to 2016 were obtained from the Surveillance, Epidemiology, and End Results 18 database. Prevalence ratios (PRs) and 95% confidence intervals (CIs) for the association between race/ethnicity and cancer diagnosis stage were calculated using Poisson regression. Analyses addressing health insurance as a potential mediator were also performed. Results: Compared with non-Hispanic Whites, racial/ethnic minorities had a higher prevalence of a distant cancer diagnosis, with PRs of 1.31 (95% CI, 1.23–1.40) for non-Hispanic Blacks, 1.14 (95% CI, 1.04–1.24) for non-Hispanic Asian/Pacific Islanders, and 1.15 (95% CI, 1.09–1.21) for Hispanics. These associations were attenuated when adjusting for health insurance, with PRs of 1.24 (95% CI, 1.16–1.33) for non-Hispanic Blacks, 1.11 (95% CI, 1.02–1.21) for non-Hispanic Asian/Pacific Islanders, and 1.07 (95% CI, 1.01–1.13) for Hispanics. Any Medicaid or no insurance at diagnosis mediated 49%, 22%, and 9% of the observed association with distant stage in Hispanics, non-Hispanic Blacks, and non-Hispanic Asian/Pacific Islanders, respectively. Conclusions: Disparities in cancer diagnosis stage in racial/ethnic minority children and adolescents may be partially explained by health insurance coverage. Further research is needed to understand the mechanisms.
AB - Background: Racial/ethnic minority children and adolescents are more likely to have an advanced cancer diagnosis compared with non-Hispanic Whites, which may relate to the lack of consistent health care access. This study aims to describe racial/ethnic disparities in cancer diagnosis stage among children and adolescents and assess whether health insurance mediates these disparities. Methods: Data on individuals ≤19 years of age diagnosed with primary cancers from 2007 to 2016 were obtained from the Surveillance, Epidemiology, and End Results 18 database. Prevalence ratios (PRs) and 95% confidence intervals (CIs) for the association between race/ethnicity and cancer diagnosis stage were calculated using Poisson regression. Analyses addressing health insurance as a potential mediator were also performed. Results: Compared with non-Hispanic Whites, racial/ethnic minorities had a higher prevalence of a distant cancer diagnosis, with PRs of 1.31 (95% CI, 1.23–1.40) for non-Hispanic Blacks, 1.14 (95% CI, 1.04–1.24) for non-Hispanic Asian/Pacific Islanders, and 1.15 (95% CI, 1.09–1.21) for Hispanics. These associations were attenuated when adjusting for health insurance, with PRs of 1.24 (95% CI, 1.16–1.33) for non-Hispanic Blacks, 1.11 (95% CI, 1.02–1.21) for non-Hispanic Asian/Pacific Islanders, and 1.07 (95% CI, 1.01–1.13) for Hispanics. Any Medicaid or no insurance at diagnosis mediated 49%, 22%, and 9% of the observed association with distant stage in Hispanics, non-Hispanic Blacks, and non-Hispanic Asian/Pacific Islanders, respectively. Conclusions: Disparities in cancer diagnosis stage in racial/ethnic minority children and adolescents may be partially explained by health insurance coverage. Further research is needed to understand the mechanisms.
KW - adolescent
KW - early diagnosis
KW - healthcare disparities
KW - neoplasm
KW - pediatric
UR - http://www.scopus.com/inward/record.url?scp=85133354723&partnerID=8YFLogxK
U2 - 10.1002/cncr.34368
DO - 10.1002/cncr.34368
M3 - Article
C2 - 35788992
AN - SCOPUS:85133354723
SN - 0008-543X
VL - 128
SP - 3196
EP - 3203
JO - Cancer
JF - Cancer
IS - 17
ER -